Ronald Weiss

Founded in 1999 by Dr. Ron Weiss and Jeff Joseph, Prescient Capital Partners is a venture capital/private equity firm located in Berwyn, Illinois. In 2007, the firm formed Prescient Advisors to provide strategic consulting services to assist entrepreneurs and CEOs of start-up, emerging and established companies in accessing resources needed to grow their businesses.

InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York.

VHS of Illinois provides healthcare services to communities throughout the northwest and southwest suburbs of Chicago. Its services include bariatrics, cancer care, heart and vascular care, hospice care, imaging and radiology, orthopedics, pain management, psychiatry and behavioral health, rehabilitation, urology, and women’s health services. The company was founded in 1919 and is headquartered in Berwyn, IL.

EyeCare Services Partners Holdings LLC provides ophthalmologic and optometric services. The company was founded in May 2014 and is headquartered in Dallas, TX.

Cellview Imaging, Inc. develops and commercializes ophthalmic imaging devices. It provides multispectral, hyperspectral, metabolic Imaging, and optical coherence tomography. The company is headquartered in Toronto, Canada.

ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI.

2C Tech Corp. develops a medical device based on nanotechnology. It offers SeeQ device, which involves intraocularly delivered photoactive nanoparticles that converts light to electrical energy similar to a conventional solar cell but on a sub-cellular scale. The company is headquartered in Irvine, CA.

Re-Vana Therapeutics Ltd. is a specialty ocular therapeutic and British drug delivery company that focuses on developing its internal pipeline and external strategic collaborations to advance its novel drug delivery platform. In 2022, Re-Vana won the Ophthalmic Innovation Summit Retina Award in drug delivery and the Belfast Nth Ireland Chamber 2022 Award for Business Innovation. Re-Vana Therapeutics was founded in 2016 as a spin-out from Queen's University, with the main office located in Belfast, UK, and an office, Re-Vana Therapeutics, Inc., based elsewhere. The company has raised more than $17.75m to support the development of sustained release biologics. In 2019, Re-Vana secured funding from Innovate totaling more than $400k to support the development of a sustained release drug. Additionally, in 2020, the company entered into a strategic feasibility collaboration with a leading pharmaceutical company for a novel therapeutic.

Visibly, Inc. develops a platform to perform an online eye exam. It operates as a healthcare technology firm that offers the convenient and affordable way to get a prescription for glasses and contacts. The firm’s technology provides valid glasses and contact lens prescriptions online from the convenience of home. The company was founded by Aaron Dallek and Steven Lee in 2012 and is headquartered in Chicago, IL.